Licenses to the Cech Patents and Ribozyme Technology. RPI has fully complied, and will use its best efforts to remain in material compliance with, and is not in breach of, and this Agreement will not materially breach, any terms, conditions or obligations of all the RPI licenses to the Cech Patents and Ribozyme Technology.
Appears in 5 contracts
Samples: Research Collaboration and License Agreement (Ribozyme Pharmaceuticals Inc), Research Collaboration and License Agreement (Ribozyme Pharmaceuticals Inc), Research Collaboration and License Agreement (Ribozyme Pharmaceuticals Inc)
